Article Outline

Article Information

PubMed

Related Articles

  • …more

Copyright © 2006 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 91, Issue 11, L96-L98, 1 December 2006

doi:10.1529/biophysj.106.090449

Biophysical Letters

Quantitative Morphological Analysis Reveals Ultrastructural Diversity of Amyloid Fibrils from α-Synuclein Mutants

Martijn E. van Raaij*Ine M.J. Segers-Nolten and Vinod Subramaniam*Go To Corresponding Author 

* MESA+ Institute for Nanotechnology, Biophysical Engineering Group, Faculty of Science and Technology, University of Twente, 7500 AE Enschede, The Netherlands
BMTI Institute for Biomedical Technology, Biophysical Engineering Group, Faculty of Science and Technology, University of Twente, 7500 AE Enschede, The Netherlands

Address reprint requests and inquiries to Vinod Subramaniam.

Abstract

High resolution atomic force microscopy is a powerful tool to characterize nanoscale morphological features of protein amyloid fibrils. Comparison of fibril morphological properties between studies has been hampered by differences in analysis procedures and measurement error determination used by various authors. We describe a fibril morphology analysis method that allows for quantitative comparison of features of amyloid fibrils of any amyloidogenic protein measured by atomic force microscopy. We have used tapping mode atomic force microscopy in liquid to measure the morphology of fibrillar aggregates of human wild-type α-synuclein and the disease-related mutants A30P, E46K, and A53T. Analysis of the images shows that fibrillar aggregates formed by E46K α-synuclein have a smaller diameter (9.0±0.8nm) and periodicity (mode at 55nm) than fibrils of wild-type α-synuclein (height 10.0±1.1nm; periodicity has a mode at 65nm). Fibrils of A30P have smaller diameter still (8.1±1.2nm) and show a variety of periodicities. This quantitative analysis procedure enables comparison of the results with existing models for assembly of amyloid fibrils.

The misfolding of proteins is at the heart of many human diseases (see, for example, 1,2,3,4). In Parkinson’s disease, the misfolding and subsequent aggregation of the natively unfolded protein α-synuclein is an essential factor 5. In familial forms of Parkinson’s disease, three point mutations in the α-synuclein gene have been identified that result in single amino acid substitutions in the α-synuclein protein: A30P, E46K, and A53T 6,7,8. Differences in the aggregation kinetics and/or aggregate morphology among the mutant proteins may yield new insights into the general process of protein misfolding and aggregation.

The nanoscale morphology of amyloid fibrils can be visualized with atomic force microscopy (AFM) or electron microscopy (see, for example, 9,10). The aggregation of α-synuclein into mature fibrils has been described by models based on AFM images 11 and is supposed to proceed through various stages, each with characteristic morphological features such as typical fibril heights and periodicities.

Although there are many studies on the morphology of fibrillar aggregates of various amyloidogenic proteins, there has been little uniformity in the analysis and description of fibril characteristics 11. In this Letter, we describe a quantitative analysis procedure that is applicable to atomic force micrographs of amyloid fibrils originating from any amyloidogenic protein. The procedure (Fig. 1) takes into account the limitations of the physical process of imaging a biological sample with atomic force microscopy, such as tip-sample convolution.

Display large version of this figure
Figure 1
Amyloid fibril characterization procedure applied to an E46K α-synuclein fibril. The top panel shows an AFM topography image of an α-synuclein fibril (left panel) with a manually drawn (ImageJ 12) segmented line profile (right panel) on the curved fibril. The bottom panel shows the corresponding height along the profile. The length ab is considered the fibril length (a and b are placed just inside the ramp-up and ramp-down, which are ignored because of tip-sample convolution). The reported fibril height is the average height between a and b. The periodicity of the fibril is calculated as the distance cd divided by, in this case, 15 periods. The “typical” peak and trough heights are indicated by e and f. Finally, the height difference ef is the measured modulation depth (see Fig. 4 for comments on the interpretation). There is a certain subjectivity in the choice of which peaks to consider “typical”, due to the limited spatial resolution of the image (in this case, the lateral resolution is 11 nm/pixel) and due to possible peak height variations in the fibril itself.

We applied the quantitative image analysis procedure to AFM images (made in tapping mode and in liquid) of fibrils of wild-type and mutant α-synuclein formed after 72h of aggregation 13. The analysis reveals grossly similar morphology but varying heights and periodicities among the disease-related mutants (Table 1). Fibrils from A30P and E46K α-synuclein appear smaller in height and correspondingly lower in peak height, trough height, and modulation depth than wild-type fibrils. Height measurements of wild-type α-synuclein fibrils in this study are consistent with those measured by others. We measure 10.0±1.1nm average height for the fibrils formed by wild-type α-synuclein, as compared to 11±2nm 14 and 9.8±1.2nm 11.

Most E46K fibrils display a periodicity of around 55nm (as in Figure 2A), but much larger periodicities (Figure 2B) or unperiodic fibrils (Figure 2C) are also observed. The periodicities of E46K and wild-type α-synuclein fibrils have modes at 55 and 65nm, respectively, and fibrils formed by A30P α-synuclein display a wider variety of periodicities (Fig. 3).

Display large version of this figure
Figure 2
Tapping mode atomic force micrograph of E46K α-synuclein in liquid after 72h of aggregation. The color scale represents 17.6nm in height. The fibril fragments marked A, B, and C are profiled along their length in the bottom panel indicating the range of morphologies observed in E46K fibrils. Vertical scale bar 2nm; horizontal scale bar, 200nm.
Display large version of this figure
Figure 3
Distribution of periodicities in fibrils of disease-related α-synuclein mutants. Wild-type and E46K α-synuclein fibrils have modes at 65 and 55nm, respectively. A30P shows a wider variety of periodicities. Histogram bin size is 10nm.

Quantitative discussion of morphological features of objects studied by AFM requires consideration of the influence of scanning system properties on the resulting image. One of the main limiting factors in deriving fibril properties from AFM images is tip-sample convolution, as evidenced by the large difference between the apparent width and the height of fibrils that are expected to be approximately round in cross section.

To assess the reliability of the measured parameters, we use a simple one-dimensional model for tip-sample convolution (Fig. 4). From Figure 4A, it follows that the tip radius is rt=w2/16rs, and the lowest measurable trough height can be calculated based on Figure 4B (see Supplementary Material ). In the case of our α-synuclein fibrils, the trough height is overestimated in the images since the tip radius is large relative to the periodicity. This complicates attributing the observed periodicity to a supposed helical structure of the fibrils. We consider the measurements of the periodicity to be reliable since they were found to be equivalent for fibrils in any orientation with respect to the scan direction, and because the tip radius does not affect the periodicity observed but only the modulation depth, as shown in Figure 4B.

Display large version of this figure
Figure 4
Simple one-dimensional models for tip-sample convolution for helical fibrils. Figure 4A allows calculation of the tip radius assuming the tip (green) is spherical and the sample (red) has a spherical cross section (see Supplementary Material ). Figure 4B models the apparent trough height for a tip with given radius scanning along the length of a double helical fibril. rt, tip radius; rs, sample radius; w, apparent width; o, contact point; c, tip center; t, apparent trough position; and p, periodicity.

In the hierarchical assembly model of α-synuclein fibril formation, as proposed by Khurana et al. 11, the trough height would be yt=(3/2)d, where d is the protofibril diameter (equal to the radius of the mature fibril rs). We can now compare the trough height values as modeled with the tip-sample convolution model, as modeled with the hierarchical assembly model, and as actually measured, for two fibrils with a different periodicity (Table 2). Based on this comparison, we conclude that the morphological features we observe are those one would expect of fibrils formed by twisted protofibrils, but we note that the lateral resolution of our images is not high enough to prove unambiguously that this model is indeed correct.

This study introduces a quantitative morphological analysis procedure of fibrillar aggregates of amyloidogenic proteins. We show that high-resolution atomic force microscopy under sample-favorable imaging conditions (imaging under buffer, low tapping amplitude (∼4nm), and low interaction force), combined with detailed image analysis, allows nanoscale comparison of fibrils formed by human wild-type α-synuclein and disease-related α-synuclein mutants. The fibrils formed by the disease-related mutants have a similar overall morphology, but a smaller diameter and a different periodicity than fibrils formed by wild-type α-synuclein. The observed fibril morphology is compatible with the hierarchical assembly model of α-synuclein fibrillization described in Khurana et al. 11. We emphasize that great care should be taken in deriving structural models from AFM data. We believe that the careful quantitative approach to determining fibril morphological characteristics reported here should be used more widely, and will be of increasing importance considering the growing number of studies that use advanced scanning probe microscopies for nanometer scale characterization of fibrils.

Acknowledgements

The authors thank Kirsten van Leijenhorst for protein expression and purification, and Kees van der Werf for expert advice on atomic force microscopy.

This work is part of the research programme of the Stichting voor Fundamenteel Onderzoek der Materie, which is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

References and Footnotes

1. Uversky, V., and Fink, A. (2004). Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 1698, 131–153. PubMed

2. Dobson, C.M. (2003). Protein folding and misfolding. Nature 426, 884–890. CrossRef | PubMed

3. Soto, C. (2003). Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49–60. PubMed

4. Forman, M.S., Trojanowski, J.Q., and Lee, V.M.Y. (2004). Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10, 1055–1063. CrossRef | PubMed

5. Lundvig, D., Lindersson, E., and Jensen, P.H. (2005). Pathogenic effects of α-synuclein aggregation. Brain Res. Mol. Brain Res. 134, 3–17. CrossRef | PubMed

6. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997). Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047. CrossRef | PubMed

7. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B., et al. (2004). The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164–173. CrossRef | PubMed

8. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L., and Riess, O. (1998). Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat. Genet 18, 106–108. CrossRef | PubMed

9. Hoyer, W., Cherny, D., Subramaniam, V., and Jovin, T. (2004). Rapid self-assembly of α-synuclein observed by in situ atomic force microscopy. J. Mol. Biol. 340, 127–139. CrossRef | PubMed

10. Choi, W., Zibaee, S., Jakes, R., Serpell, L.C., Davletov, B., Anthony Crowther, R., and Goedert, M. (2004). Mutation E46K increases phospholipid binding and assembly into filaments of human α-synuclein. FEBS Lett. 576, 363–368. CrossRef | PubMed

11. Khurana, R., Ionescu-Zanetti, C., Pope, M., Li, J., Nielson, L., Ramirez-Alvarado, M., Regan, L., Fink, A.L., and Carter, S.A. (2003). A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. Biophys. J. 85, 1135–1144. Abstract | Full Text | PDF (427 kb) | PubMed

12. Rasband, W. S. 1997–2006. ImageJ. http://rsb.info.nih.gov/ij/..

13. See Supplementary Material for protein expression, purification and aggregation, and AFM imaging conditions..

14. Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T.M., and Subramaniam, V. (2002). Dependence of α-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 322, 383–393. CrossRef | PubMed

Publication Information


Received: June 2, 2006
Accepted: September 5, 2006